MBC BioLabs Announces New Partnership with Quantum-SI

[San Francisco, CA – June 2, 2025] – MBC BioLabs is proud to announce it has entered into a partnership with Quantum-SI. This partnership will help support the mission of enabling awesome for MBC BioLabs’ community of high-growth biotech start-up companies.

We invite you to join us at noon in the MBC BioLabs campus at 930 Brittan Ave in San Carlos on June 3 for a celebration and launch of this exciting partnership.

Registration required: Register →

About Quantum-SI
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

About MBC BioLabs
At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems.

We have helped launch and grow over 400 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 135 products to market, and collectively raised over $20 billion. Learn more at mbcbiolabs.com.